- Daiichi Sankyo, Inc. (Bernards, NJ)
- …other research areas centered around rare diseases and immune disorders. SummaryThe Executive Director , Global Oncology Medical Affairs, External ... This role and their team will partner closely across several functions within Global Oncology Medical Affairs, Regional Medical Affairs, R&D functions,… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …areas centered around rare diseases and immune disorders. SummaryThe Associate Director Global Medical Affairs Oncology (GMA), under the direction of the ... Senior Director / Director , GMA Oncology ( Global Medical Affairs team lead for compound), is responsible for assisting with defining compound/program … more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …areas centered around rare diseases and immune disorders. SummaryAs a core member of the Global Oncology Medical Affairs (GOMA) Leadership Team, this role is ... role and their team will partner closely across several functions within Global Oncology Medical Affairs, Regional Medical Affairs, Precision Medicine,… more
- Daiichi Sankyo, Inc. (Philadelphia, PA)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …compound under the supervision and leadership of the Executive Director of Medical Research and Strategy, US Oncology Medical Affairs (USOMA). Develops ... diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology...Launch Readiness activities and life cycle management from a medical perspective- Participates in Global Medical… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... cross-functional partners and if applicable, Alliance counterparts.Responsibilities- Partners with US Medical Affairs Oncology and stakeholders in Daiichi Sankyo… more
- Daiichi Sankyo, Inc. (Philadelphia, PA)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... and aligned strategy.Responsibilities:Operational Strategy and Oversight:Align with the Senior Director , Global Clinical Operations on plans for successful… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...disorders. Under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... is primarily focused on providing novel therapies in oncology , as well as other research areas centered around...well as domestic and international trips to participate in global communications conferences and events, and potentially medical… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …hours per week. Responsibilities: Daiichi Sankyo Inc's Oncology Publications team within Global Oncology Medical Affairs (GOMA) is seeking a Publications ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology… more
- Bristol Myers Squibb (Princeton, NJ)
- …. **Position Summary** The Associate Director , Portfolio Delivery Lead, in Global Medical Oncology (GMO), plays a critical role in ... role will report to the Senior Director , Portfolio Strategy Lead, Global Medical Oncology . **Key Responsibilities** + Lead the execution of initiatives… more
- Bristol Myers Squibb (Princeton, NJ)
- …first in class EGFRxHER3 bispecific ADC, iza-bren in US, and outside of China. The Global Medical Director , for Iza-bren will serve as the strategic and ... operational leader for the global medical strategy of the Iza-bren asset,...insights and foster scientific exchange. + Represent BMS at global oncology congresses and forums, elevating the… more
- Bristol Myers Squibb (Princeton, NJ)
- …execution of BMS' WW & US medical strategy within our Thoracic/H&N portfolio. The Global Medical Oncology IO Thoracic/H&N Medical Product Lead (MPL) ... plans as a lead of the cross functional Asset/Indication Medical Strategy (AIMS) team. The Senior Director ,...senior medical leader will report to the Global Medical Oncology Disease Area… more
- Bristol Myers Squibb (Princeton, NJ)
- …Summary** The primary responsibility of the Director for IO Lung Cancer in Global Medical , with a focus on the US, is to develop and implement the US ... relationships with key stakeholders, including, but not limited to, US Commercialization, Global Medical , Clinical Development, and Medical Capabilities… more
- Bristol Myers Squibb (Princeton, NJ)
- …personal lives. Read more: careers.bms.com/working-with-us . **Position Summary:** The Senior Director , Global Commercial Strategy Oncology , BioNTech/Solid ... Tumor will be a key member of the Oncology Global Commercial Strategy team, responsible for...objectives. + Partner closely with Tumor Leads, Business Development, Medical , Market Access, and other stakeholders to drive integrated… more
